BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 30284120)

  • 21. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy.
    Onor IO; Ahmed F; Nguyen AN; Ezebuenyi MC; Obi CU; Schafer AK; Borghol A; Aguilar E; Okogbaa JI; Reisin E
    Am J Med Sci; 2024 Jan; 367(1):4-13. PubMed ID: 37832917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
    Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
    Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less Really Is More in Inappropriate Medication Use in Older Adults: How Can We Improve Prescribing and Deprescribing in Older Adults?
    Fick DM
    J Am Geriatr Soc; 2020 Jun; 68(6):1175-1176. PubMed ID: 32364621
    [No Abstract]   [Full Text] [Related]  

  • 26. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
    van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
    Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 29. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
    Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
    Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
    Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
    Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
    Zidan A; Awaisu A
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients.
    Duncan I; Maxwell TL; Huynh N; Todd M
    Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
    Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
    Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation and cultural adaptation of MedStopper®-A web-based decision aid for deprescribing in older adults: A protocol.
    Monteiro L; Baptista S; Ribeiro-Vaz I; McCormack J; Matos C; Teixeira A; Monteiro-Soares M; Martins C
    PLoS One; 2023; 18(4):e0284464. PubMed ID: 37079629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.
    Levy HB
    Clin Geriatr Med; 2017 May; 33(2):177-187. PubMed ID: 28364990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stakeholder Perspectives on Factors Related to Deprescribing Potentially Inappropriate Medications in Older Adults Receiving Dialysis.
    Hall RK; Rutledge J; Lucas A; Liu CK; Clair Russell JS; Peter WS; Fish LJ; Colón-Emeric C
    Clin J Am Soc Nephrol; 2023 Oct; 18(10):1310-1320. PubMed ID: 37499693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
    Ross SB; Wilson MG; Papillon-Ferland L; Elsayed S; Wu PE; Battu K; Porter S; Rashidi B; Tamblyn R; Pilote L; Downar J; Bonnici A; Huang A; Lee TC; McDonald EG
    J Am Geriatr Soc; 2020 Aug; 68(8):1636-1646. PubMed ID: 32441771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
    Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.